Susceptibility to murine cytomegalovirus retinitis during progression of MAIDS: Correlation with intraocular levels of tumor necrosis factor-α and interferon-γ

Current Eye Research

Volumn 29, Issue 2-3, 2004, Pages 173-180

  Dix, Richard D ^a   Cousins, Scott W ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Cytomegalovirus retinitis; Interferon ; Murine AIDS (MAIDS); Murine cytomegalovirus; Tumor necrosis factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMETRY; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; HISTOPATHOLOGY; INTERFERON PRODUCTION; MOUSE; MURINE CYTOMEGALOVIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINITIS; RODENT DISEASE; TH1 CELL; TH2 CELL; VIRUS PLAQUE; VIRUS REPLICATION;

ANIMALS; CYTOMEGALOVIRUS RETINITIS; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; EYE; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; MUROMEGALOVIRUS; NECROSIS; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 9344232812     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490504876     Document Type: Conference Paper

References (42)

1. Bloom JN, Palestine AG. The diagnosis of cytomegalovirus retinitis. Ann Intern Med. 1988;109:963-969.
2. Fay MT, Freeman WR, Wiley CA, Hardy D, Bozzette S. Atypical retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol. 1988;105:483-490.
3. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107:75-80.
4. Jabs DA, Bartlett JG. AIDS and ophthalmology: A period of transition. Am J Ophthalmol. 1997;124:227-233.
5. Palella FJ Jr, Delaney KM, Moorman AC, Loveless JO, Fuhrer J, Satten DJ, Aschman J, Homberg SD, Loveless MO, Satten GA, Aschman DJ, and the HIV Outpatient Study Investigators. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
6. Jacobson MA, Stanley S, Holtzer C, Margolis TP, Cunningham ET. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;30:231-233.
7. Cunningham ET, Margolis TP. Ocular manifestations of HIV infection. N Engl J Med. 1998;339:236-244.
8. Holland GN, Tufail A, Jordan C. Cytomegalovirus diseases. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular Infection & Immunity. St. Louis: Mosby Press; 1996: 1088-1130.
9. Dix RD, Cray C, Cousins SW. Mice immunosuppressed by murine retrovirus infection (MAIDS) are susceptible to cytomegalovirus retinitis. Curr Eye Res. 1994;13:587-595.
10. Mosier DE, Yetter RA, Morse HC III. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J Exp Med. 1985;161:766-784.
11. Morse HC III, Yetter RA, Via CS, Hardy RR, Cerny A, Hayakawa K, Hugin AW, Miller MN, Holmes KL, Shearer GM. Functional and phenotypic alterations in T cell subsets during the course of MAIDS, a murine retrovirus-induced immunodeficiency syndrome. J Immunol. 1989;143: 844-850.
12. Hartley JW, Frederickson TN, Yetter RA, Makino M, Morse HC III. Retrovirus-induced murine acquired immunodeficiency syndrome: Natural history of infection and differing susceptibility of inbred mouse strains. J Virol. 1989; 63:1223-1231.
13. Morse HC III, Chattopadhyay SK, Makino M, Fredrickson TN, Hugin AW, Hartley JW. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model of AIDS. AIDS 1992;6:607-621.
14. Jolicoeur P. Murine acquired immunodeficiency syndrome (MAIDS): An animal model to study AIDS pathogenesis. FASEB J. 1991;5:2398-2405.
15. Gazzinelli RT, Makino M, Chattopadhyay SK, Snapper CM, Sher A, Hugin AW, Morse HC III. CD4+ subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immunodeficiency in mice. J Immunol. 1992;148:182-188.
16. Clerici M, Shearer GM. A TH1 - TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993;14:107-111.
17. Dix RD, Giedlin M, Cousins SW. Systemic cytokine immunotherapy for experimental cytomegalovirus retinitis in mice with retrovirus-induced immunodeficiency. Invest Ophthalmol Vis Sci. 1997;38:1411-1417.
18. Cousins SW, Rouse BT. Chemical mediators of ocular inflammation. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular Infection & Immunity. St. Louis: Mosby Press; 1996:50-70.
19. Biron CA, Sen GC. Interferons and other cytokines. In: Knipe DM, Howley PM, editors. Fields Virology, Fourth Edition. Philadelphia: Lippincott Williams & Wilkins; 2001:321-351.
20. Atherton SS, Newell CK, Kanter MY, Cousins SW T cell depletion increases susceptibility to murine cytomegalovirus retinitis. Invest Ophthalmol Vis Sci. 1992; 33:3353-3360.
21. Dix RD, Cray CC, Cousins SW. Antibody alone does not prevent experimental cytomegalovirus retinitis in mice with retrovirus-induced immunodeficiency (MAIDS). Ophthalmic Res. 1997;29:381-392.
22. Dix RD, Cousins SW. Interleukin-2 immunotherapy of murine cytomegalovirus retinitis during MAIDS correlates with increased intraocular CD8+ T-cell infiltration. Ophthalmic Res. 2003;35:154-159.
23. Dix RD, Podack ER, Cousins SW. Loss of the perform cytotoxic pathway predisposes mice to experimental cytomegalovirus retinitis. J Virol. 2003;77:3402-3408.
24. Gao EK, Yu XH, Lin CP, Zhang H, Kaplan HJ. Intraocular viral replication after systemic murine cytomegalovirus infection requires immunosuppression. Invest Ophthalmol Vis Sci. 1995;36:2322-2327.
25. Dix RD. Systemic murine cytomegalovirus infection of mice with retrovirus-induced immunodeficiency results in ocular infection but not retinitis. Ophthalmic Res. 1998;30:295-301.
26. Epstein LG, Gendelman HE, Lipton ST. Human immunodeficiency virus-1 neuropathogenesis. In: Berger JR, Levy RM, editors. AIDS and the Nervous System, Second Edition. Philadelphia: Lippincott-Raven; 1997:59-75.
27. Merrill JE, Koyanagi Y, Chen ISY. Interleukin-1 and tumor necrosis factor-α can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor: Production of cytotoxic factor for oligodendrocytes. J Virol. 1989;63:4404-4408.
28. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrach Y, Volsky DJ. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astrocyte interactions: Implications for the neuropathogenesis of HIV disease. J Exp Med. 1992;176:1703-1718.
29. Lieberman AP, Pitha PM, Shin HS, Shin ML. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or neurotropic virus. Proc Nat Acad Sci USA. 1989;86:6348-6352.
30. Lachman LB, Brown DC, Dinarello CA. Growth-promoting effects of recombinant interleukin-1 and tumor necrosis factor for a human astrocyte cell line. J Immunol. 1987;138:2913-2916.
31. Selmaj KW, Faroog M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitro in response to cytokines: A primary role for tumor necrosis factor. J Immunol. 1990;144:129-135.
32. Massa PT, Schimpl A, Wecker E, ter Meulin V. Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes. Proc Nat Acad Sci USA. 1987;84: 7242-7245.
33. Bigger JE, Tanigawa M, Zhang M, Atherton SS. Murine cytomegalovirus infection causes apoptosis of uninfected retinal cells. Invest Ophthalmol Vis Sci. 2000;41: 2248-2254.
34. Zhang M, Atherton SS. Apoptosis in the retina during MCMV retinitis in immunosuppressed BALB/c mice. J Clin Virol. 2002;25:S137-S147.
35. Pulliam L, Moore D, West DC. Human cytomegalovirus induces IL-6 and TNF alpha from macrophages and microglial cells: Possible role in neurotoxicity. J Neurovirol. 1995;1:219-227.
36. Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression. J Clin Invest. 1994;93:474-478.
37. Hanson LK, Slater JS, Karabekian Z, Virgin HW, Biron CA, Ruzek MC, van Rooijen N, Ciavarra RP, Stenberg RM, Campbell AE. Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J Virol. 1999;73:5970-5980.
38. Haagmans BL, van den Eertwegh AJ, Claassen E, Horzinek C. Tumor necrosis factor-α production during cytomegalovirus infection in immunosuppressed rats. J Gen Virol. 1994;75:779-787.
39. Hofman F, Hinton DR. Tumor necrosis factor-α in the retina in acquired immune deficiency syndrome. Invest Ophthalmol Vis Sci. 1992;33:1829-1835.
40. Tilg H, Vogel W, Herold M, Aulitzky WE, Huber C. Cachexia and tumor necrosis factor-α in cytomegalovirus infection. J Clin Pathol. 1991;44:519-520.
41. Smith PD, Saini SS, Raffeld M, Manischewitz JF, Wahl SM. Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages. J Clin Invest. 1992;90:1642-1648.
42. Dix RD, Cousins SW. Murine cytomegalovirus retinitis during MAIDS: Susceptibility correlates with elevated intraocular levels of interleukin-4 mRNA. Curr Eye Res. 2003;26:211-217.